Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02328014
Title ACP-196 in Combination With ACP-319, for Treatment of B-Cell Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Acerta Pharma BV
Indications

mature B-cell neoplasm

multiple myeloma

B-cell lymphoma

B-lymphoblastic leukemia/lymphoma

mantle cell lymphoma

hairy cell leukemia

Therapies

ACP-319

Acalabrutinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.